Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma March 15, 2018 Type of Cancer Lymphoma Sponsor Georgetown Protocol Number Pro2016-0014 (C103287) To Learn More Call 201-510-0910
